CELULARITY INC Share Price Today: Live Updates & Key Insights

CELULARITY INC share price today is $0.75, up -1.32%. The stock opened at $0.7621 against the previous close of $0.76, with an intraday high of $0.7897 and low of $0.7615.

CELULARITY INC Share Price Chart

CELULARITY INC

us-stock
To Invest in {{usstockname}}
us-stock

CELULARITY INC Share Price Performance

$0.75 -0.0132(-1.32%) CELU at 27 Jul 2026 02:23 PM Biotechnology
Lowest Today 0.7615
Highest Today 0.7897
Today’s Open 0.7621
Prev. Close 0.76
52 Week High 4.31
52 Week Low 0.56
Day’s Range: Low 0.7615 High 0.7897
52-Week Range: Low 0.56 High 4.31
1 day return -
1 Week return +1.38
1 month return +21.04
3 month return -21.17
6 month return -39.03
1 year return -76.4
3 year return -78.31
5 year return -99.11
10 year return -

CELULARITY INC Institutional Holdings

C V Starr & Co Inc 2.64

Vanguard Group Inc 2.34

Vanguard Capital Management, LLC 2.15

Vanguard Total Stock Mkt Idx Inv 1.57

Geode Capital Management, LLC 0.66

Vanguard Institutional Extnd Mkt Idx Tr 0.57

BlackRock Inc 0.44

Fidelity Extended Market Index 0.36

Vanguard Fiduciary Trust Co 0.28

State Street Corp 0.20

Valmark Advisers, Inc. 0.17

Northern Trust Corp 0.15

HB Wealth Management, LLC 0.14

Biltmore Family Office, LLC 0.12

Keynote Financial Services, LLC 0.10

Northern Trust Extended Eq Market Idx 0.10

NT Ext Equity Mkt Index Fund - Lending 0.10

Spartan Extended Market Index Pool F 0.08

Fidelity Series Total Market Index 0.07

Fidelity Total Market Index 0.07

Royal Bank of Canada 0.06

CenterStar Asset Management, LLC 0.06

Ipg Investment Advisors, LLC 0.06

TWO SIGMA SECURITIES, LLC 0.05

Blackrock Extended Mkt Fund CF 0.05

Extended Equity Market Fund B 0.05

Extended Equity Market Fund E 0.05

NT Ext Equity Mkt Index Fund - NL 0.05

XTX Topco Ltd 0.04

HRT FINANCIAL LLC 0.04

BlackRock Extended Equity Market Fund K 0.04

Spartan Total Market Index Pool G 0.04

NT Ext Eq Mkt Idx Fd DC Lending Tier 5 0.04

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.04

Advisor Group Holdings, Inc. 0.03

Fidelity Nasdaq Composite Index 0.03

IFP Advisors, LLC 0.03

Vanguard Instl Ttl Stck Mkt Index Trust 0.02

State St US Extended Mkt Indx NL Cl C 0.01

Vanguard U.S. Eq Idx £ Acc 0.01

CELULARITY INC Market Status

Strong Buy: 0

Buy: 1

Hold: 0

Sell: 0

Strong Sell: 0

CELULARITY INC Fundamentals

Market Cap 22.00 M

PB Ratio 9.8919

PE Ratio 0.0

Enterprise Value 57.30 M

Total Assets 107.33 M

Volume 48115

CELULARITY INC Company Financials

Annual Revenue FY24:22771000 22.8M, FY23:14788000 14.8M, FY22:17975000 18.0M, FY21:21335000 21.3M, FY20:14278000 14.3M

Annual Profit FY24:6755000 6.8M, FY23:3134000 3.1M, FY22:-1690000 -1.7M, FY21:11682000 11.7M, FY20:9346000 9.3M

Annual Net worth FY24:-196295000 -196.3M, FY23:-181408000 -181.4M, FY22:14192000 14.2M, FY21:-100118000 -100.1M, FY20:-208233000 -208.2M

Quarterly Revenue Q1/2026:4104000 4.1M, Q3/2025:5284000 5.3M, Q2/2025:5736000 5.7M, Q1/2025:18132000 18.1M, Q3/2024:9296000 9.3M

Quarterly Profit Q1/2026:8556000 8.6M, Q3/2025:3266000 3.3M, Q2/2025:494000 0.5M, Q1/2025:10789000 10.8M, Q3/2024:5413000 5.4M

Quarterly Net worth Q1/2026:-24362000 -24.4M, Q3/2025:-23073000 -23.1M, Q2/2025:-24524000 -24.5M, Q1/2025:-13293000 -13.3M, Q3/2024:-16098000 -16.1M

About CELULARITY INC & investment objective

Company Information Celularity Inc., a cellular and regenerative medicine company, focuses on addressing aging-related disease using novel therapies. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It develops off-the-shelf placental-derived allogeneic cell therapy product candidates, including mesenchymal-like adherent stromal cells for diabetic foot ulcer and Crohn's disease. Its therapeutic programs include PDA-001 for the treatment of autoimmune (Crohn's) and degenerative disease; and PDA-002 for treating multiple sclerosis, rheumatoid arthritis, stroke, and diabetic peripheral neuropathy. The company also produces, sells, and licenses products used in surgical and wound care markets, such as Biovance, Biovance 3L, Rebound, Interfyl, and Centaflex; and collects, processes, and stores umbilical cord and placental blood and tissue after full-term pregnancies under the LifebankUSA brand. Celularity Inc. has licensing agreement with Sorrento Therapeutics, Inc. for the development and commercialization of licensed CD19 CAR-T products; and research collaboration services agreement with Regeneron Pharmaceuticals, Inc. to support the research of allogeneic cell therapy candidates. Celularity Inc. was founded in 1998 and is headquartered in Florham Park, New Jersey.

Organisation Biotechnology

Employees 115

Industry Biotechnology

CEO Dr. Robert Joseph Hariri M.D., Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

CELULARITY INC FAQs

What is the share price of CELULARITY INC today?

The current share price of CELULARITY INC is $0.75.

Can I buy CELULARITY INC shares in India?

Yes, Indian investors can buy CELULARITY INC shares by opening an international trading and demat account with Motilal Oswal.

How to buy CELULARITY INC shares in India?

You can easily invest in CELULARITY INC shares from India by:

Can I buy fractional shares of CELULARITY INC?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of CELULARITY INC?

CELULARITY INC has a market cap of $22.00 M.

In which sector does CELULARITY INC belong?

CELULARITY INC operates in the Biotechnology sector.

What documents are required to invest in CELULARITY INC stocks?

To invest, you typically need:

What is the PE and PB ratio of CELULARITY INC?

The PE ratio of CELULARITY INC is N/A and the PB ratio is 9.89.